| Q83371981 | A prototype assay to detect vCJD-infected blood |
| Q34337709 | Adhesion strength-based, label-free isolation of human pluripotent stem cells |
| Q33646206 | Amplification of distinct α-synuclein fibril conformers through protein misfolding cyclic amplification. |
| Q30784193 | An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy |
| Q35080977 | An enzymatic treatment of soil-bound prions effectively inhibits replication |
| Q64077907 | Application of PMCA to screen for prion infection in a human cell line used to produce biological therapeutics |
| Q36736021 | Aryl Diazonium Chemistry for the Surface Functionalization of Glassy Biosensors |
| Q37085882 | Cellular prion protein (PrPC) of the neuron cell transformed to a PK-resistant protein under oxidative stress, comprising main mitochondrial damage in prion diseases |
| Q102059036 | Chronic wasting disease (CWD) prion detection in blood from pre-symptomatic white-tailed deer harboring PRNP polymorphic variants |
| Q35217464 | Correlation between infectivity and disease associated prion protein in the nervous system and selected edible tissues of naturally affected scrapie sheep |
| Q92885771 | Cross-validation of the RT-QuIC assay for the antemortem detection of chronic wasting disease in elk |
| Q41091421 | Cyclic amplification of prion protein misfolding |
| Q51768808 | Deduction of the evaluation limit and termination timing of multi-round protein misfolding cyclic amplification from a titration curve. |
| Q54268880 | Design, implementation, and interpretation of amplification studies for prion detection. |
| Q36881821 | Detection and Quantification of CWD Prions in Fixed Paraffin Embedded Tissues by Real-Time Quaking-Induced Conversion. |
| Q47313313 | Detection of Prions in Blood of Cervids at the Asymptomatic Stage of Chronic Wasting Disease |
| Q40399825 | Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease |
| Q39076670 | Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease |
| Q34593983 | Development of dose-response models of Creutzfeldt-Jakob disease infection in nonhuman primates for assessing the risk of transfusion-transmitted variant Creutzfeldt-Jakob disease |
| Q33967960 | Dissociation of infectivity from seeding ability in prions with alternate docking mechanism |
| Q40564882 | Efficient propagation of variant Creutzfeldt-Jakob disease prion protein using the cell-protein misfolding cyclic amplification technique with samples containing plasma and heparin |
| Q53077013 | Enhanced prion detection in biological samples by magnetic particle extraction and real-time quaking-induced conversion. |
| Q34142610 | Enriching libraries of high-aspect-ratio micro- or nanostructures by rapid, low-cost, benchtop nanofabrication |
| Q36456289 | Fast and ultrasensitive method for quantitating prion infectivity titre |
| Q38899453 | Force transmission during adhesion-independent migration. |
| Q34476650 | Grass plants bind, retain, uptake, and transport infectious prions |
| Q35918919 | Harnessing prions as test agents for the development of broad-range disinfectants |
| Q37147766 | Identification of misfolded proteins in body fluids for the diagnosis of prion diseases |
| Q92320578 | In Vitro detection of Chronic Wasting Disease (CWD) prions in semen and reproductive tissues of white tailed deer bucks (Odocoileus virginianus) |
| Q35041621 | In vitro detection of prionemia in TSE-infected cervids and hamsters |
| Q35105375 | Initial fate of prions upon peripheral infection: half-life, distribution, clearance, and tissue uptake |
| Q40413509 | Isolation of Exosomes and Microvesicles from Cell Culture Systems to Study Prion Transmission |
| Q34051195 | Lack of prion transmission by sexual or parental routes in experimentally infected hamsters |
| Q33809070 | Measuring cell-generated forces: a guide to the available tools |
| Q37433317 | N-cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cells. |
| Q64819927 | Neurotheranostics as personalized medicines |
| Q37993987 | New generation QuIC assays for prion seeding activity |
| Q91967822 | PAD-Beads enrichment enhances detection of PrPSc using real-time quaking-induced conversion |
| Q90163542 | PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease |
| Q37693704 | Peripherally administrated prions reach the brain at sub-infectious quantities in experimental hamsters |
| Q34874108 | Plasminogen-based capture combined with amplification technology for the detection of PrP(TSE) in the pre-clinical phase of infection |
| Q92115905 | Preclinical Detection of Prions in Blood of Nonhuman Primates Infected with Variant Creutzfeldt-Jakob Disease |
| Q37596801 | Prion disease: experimental models and reality |
| Q37890298 | Prion seeded conversion and amplification assays. |
| Q37800332 | Prion transmission: prion excretion and occurrence in the environment |
| Q37215766 | Prions efficiently cross the intestinal barrier after oral administration: Study of the bioavailability, and cellular and tissue distribution in vivo. |
| Q34173236 | Prions in the urine of patients with variant Creutzfeldt-Jakob disease |
| Q37162363 | Prions: Beyond a Single Protein |
| Q38274835 | Protein misfolding cyclic amplification (PMCA): Current status and future directions. |
| Q33725480 | Protein misfolding cyclic amplification of infectious prions |
| Q47154833 | Protocol for further laboratory investigations into the distribution of infectivity of Atypical BSE |
| Q33925227 | Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection |
| Q34802813 | Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals |
| Q33769767 | Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays |
| Q35036649 | Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent |
| Q35146011 | Replication and spread of CJD, kuru and scrapie agents in vivo and in cell culture |
| Q34982680 | Replication efficiency of soil-bound prions varies with soil type |
| Q93088815 | Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification |
| Q37730775 | Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche. |
| Q93144118 | Sodium hydroxide treatment effectively inhibits PrPCWD replication in farm soil |
| Q48381755 | Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders |
| Q34742787 | Superparamagnetic nanoparticle capture of prions for amplification |
| Q56559501 | Susceptibility of Human Prion Protein to Conversion by Chronic Wasting Disease Prions |
| Q64276769 | Synthesis of Fe₃C@C from Pyrolysis of Fe₃O₄-Lignin Clusters and Its Application for Quick and Sensitive Detection of PrP through a Sandwich SPR Detection Assay |
| Q40508335 | The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases |
| Q42271639 | Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays |
| Q38718288 | Treatment with a non-toxic, self-replicating anti-prion delays or prevents prion disease in vivo. |